Success Metrics

Active Trials

6(86%)

Phase Distribution

Ph phase_1

29%

Ph phase_2

71%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

2(28.6%)

Phase 2Efficacy & side effects

5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(6)

Other(1)

Detailed Status

Recruiting6

Suspended1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 12 (28.6%)

Phase 25 (71.4%)

Trials by Status

suspended114%

recruiting686%

Recent Activity

6 active trials

Showing 5 of 7

recruitingphase_2

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

NCT04906096

recruitingphase_2

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

NCT03970447

recruitingphase_2

Combination Therapy for the Treatment of Diffuse Midline Gliomas

NCT05009992

recruitingphase_2

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

NCT07447076

recruitingphase_1

5G-PEARL: Paxalisib in Malignant Brain Tumours

NCT07391215

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04906096Phase 2

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

Recruiting

NCT03970447Phase 2

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Recruiting

NCT05009992Phase 2

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Recruiting

NCT07447076Phase 2

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Recruiting

NCT07391215Phase 1

5G-PEARL: Paxalisib in Malignant Brain Tumours

Recruiting

NCT06208657Phase 1

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Recruiting

NCT05183204Phase 2

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Suspended

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7